Getinge announces its commitment to EuroPCR.

May 15, 2018
Paris, France

Getinge, a leading global provider of innovative medical technology, announces today that it will be exhibiting at EuroPCR - the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI).

“Getinge is excited to participate in this world leading course in Interventional Cardiovascular Medicine. EuroPCR attracts over 12,000 participants from around the world - interventional cardiologists, nurses, technicians and scientists – enabling Getinge to share the latest developments, and an opportunity to discuss how to treat cardiovascular conditions. It also provides a great platform to showcase our cardiovascular portfolio including Cardiohelp, Cardiosave and the Advanta V12 Balloon Expandable Covered Stent.” shared Markus Stirner-Schilling, Senior Director, Acute Care Therapies, Global Commercial Operations.

About Getinge at EuroPCR:

Registered visitors are invited to visit Getinge on Booth P2, Hall Paris from May 22nd – 25th at Palais des Congrès,2 Place de la Porte Maillot,75017 Paris, France.

For further information, please contact

Tracey Dawe
Director Communications - Global Sales
Phone: + 44 77 177 84965   Email: tracey.dawe@getinge.com

About Getinge

Getinge is a global provider of innovative solutions for operating rooms, intensive-care units, sterilization departments and for life science companies and institutions. Based on our first-hand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving every-day life for people, today and tomorrow.

Tags:

About Us

Getinge is a global provider of innovative solutions for operating rooms, intensive-care units, sterilization departments and for life science companies and institutions. Based on our first-hand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving the every-day life for people, today and tomorrow.